| Trial ID: | L7201 |
| Source ID: | NCT00214253
|
| Associated Drug: |
Thiazolidinedione
|
| Title: |
Islet Transplantation in Type 1 Diabetic Patients
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 1 Diabetes
|
| Interventions: |
DRUG: Thiazolidinedione
|
| Outcome Measures: |
Primary: number of islets necessary to achieve adequate metabolic control, 5 years|post-transplant islet function, 5 years | Secondary: Suitability of cadaver donor pancreases for islet transplantation, 5 years
|
| Sponsor/Collaborators: |
Sponsor: University of Wisconsin, Madison
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
14
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2002-02
|
| Completion Date: |
2011-10
|
| Results First Posted: |
|
| Last Update Posted: |
2017-03-31
|
| Locations: |
University of Wisconsin, Madison, Wisconsin, 53792, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00214253
|
